trial
as of 2026-07-01Impact of VVV Group for Veterans With SMI
NCTId NCT05562674
at a glance
— · Completed
Enrollment 28 (actual)
Sponsored by VA Office of Research and Development
Primary completion 2025-03-01
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Completed
Enrollment
28 (actual)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2024-03-18
Primary completion
2025-03-01
Eligibility
ALL · 18 Years
Interventions & indications
Sponsors
VA Office of Research and DevelopmentLead Sponsor
Investigators
1
Ippolytos A Kalofonos, MD PhD MPHPrincipal Investigator
Sites
1 total
West Los Angeles, United States
Facts & assertions
4 sourced
Enrollment
28
Phase
NA
Primary Completion Date
2025-03-01
Status
COMPLETED
relationships
The graph out of here
drug
lead_sponsor
indication
investigator